Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Effect of Neutralizing Anti-AAV Antibodies on Vector Transduction Following Intravitreal Administration of AAV in Non-Human Primates

Heikki Turunen; Adrian M Timmers; Judith Newmark; Steven Pennock; mark s shearman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2911.

ARVO Annual Meeting Abstract July 2019

Controlling Inflammation and the Immune Response after Intravitreal Injection with Post-Processing of AAV Vectors and Modulation of Capsid and Viral Genome Titers

Adrian M Timmers; Judith Newmark; Heikki Turunen; Tanaz Farivar; Chunjuan Song; Guo-jie Ye; Steven Pennock; David Knop; Katie Beasley; mark s shearman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2912.

ARVO Annual Meeting Abstract June 2013

Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a non-angiogenic blinding disease

Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2849.

ARVO Annual Meeting Abstract June 2013

Epithelial cells promote fibroblast-mediated contraction of collagen gels by secreting bFGF

Maryada Sharma; Hetian Lei; Steven Pennock; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6258.

ARVO Annual Meeting Abstract April 2011

A Novel Strategy To Develop Therapeutic Approaches To Prevent Proliferative Vitreoretinopathy

Steven Pennock; Marc-Andre Rheaume; Shizuo Mukai; Joanne A. Matsubara; Jing Cui; David Maberley; Patrick Ma; Arif Samad; R.J. van Geest; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4924.

ARVO Annual Meeting Abstract April 2009

Characterization of the Vitreal Factors Associated With PVR Pathology and Severity

S. Pennock; M. Kuhnle; D. W. Chun; A. Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2711.

Advertisement